Scheme of Amalgamation
Related Links
- Draft Scheme of AmalgamationPDF | 731KB
- Valuation ReportPDF | 371KB
- Audit Committee ReportPDF | 850KB
- Fairness OpinionPDF | 2MB
- Pre and Post Shareholding Pattern of the Transferee and Transferor CompanyPDF | 5MB
- Financial details of last three years of Transferee Company and Transferor CompanyPDF | 478KB
- Auditor CertificatePDF | 1011KB
- Underaking Para 9(a) & (b) of SEBI Circular on Scheme of ArrangementPDF | 749KB
- Compliance ReportPDF | 493KB
- Observation Letter - NSEPDF | 295KB
- Observation Letter - BSEPDF | 166KB
13-12-2018: The Scheme of Amalgamation between the Company and GlaxoSmithKline Consumer Healthcare Limited (GSK CH), and their respective shareholders and creditors, pursuant to the provisions of Sections 230 to 232 and other applicable provisions of Companies Act, 2013, approved by the Board of Directors in their meeting held on 3rd December, 2018 has been submitted with National Stock Exchange of India Limited and BSE Limited.